Haleon CFO Brian McNamara acquires 12,208 shares
The transaction entries list two sterling-denominated prices and one U.S.-dollar price for September 22 acquisitions.
Rhea-AI Filing Summary
Haleon plc (HLN) disclosed acquisitions of ordinary shares through dividend reinvestment by Chief Financial Officer Dawn Allen and Chief Financial Officer Brian McNamara, plus a further transaction entry. On September 22, 2026, Dawn Allen acquired 2,317.19703 shares at £3.44631, and Brian McNamara acquired 12,208.83196 shares at £3.44631.
The further transaction entry reports an acquisition of 2,139.05113 ordinary shares at $9.3801 on September 22, 2026. Each entry identifies dividend reinvestment as the transaction type and the London Stock Exchange as the transaction place.
Positive
- None.
Negative
- None.
Key Figures
Dawn Allen dividend-reinvestment shares: 2,317.19703 ordinary shares
Dawn Allen transaction price: £3.44631
Brian McNamara dividend-reinvestment shares: 12,208.83196 ordinary shares
+3 more
6 metrics
Dawn Allen dividend-reinvestment shares
2,317.19703 ordinary shares
Acquired September 22, 2026
Dawn Allen transaction price
£3.44631
Dividend-reinvestment acquisition on September 22, 2026
Brian McNamara dividend-reinvestment shares
12,208.83196 ordinary shares
Acquired September 22, 2026
Brian McNamara transaction price
£3.44631
Dividend-reinvestment acquisition on September 22, 2026
Further transaction shares
2,139.05113 ordinary shares
Dividend-reinvestment acquisition on September 22, 2026
Further transaction price
$9.3801
Dividend-reinvestment acquisition on September 22, 2026
Key Terms
dividend reinvestment, Persons Discharging Managerial Responsibilities, PDMR/PCA, LEI
4 terms
dividend reinvestment financial
"Acquisition of Ordinary Shares as a result of dividend reinvestment"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
Persons Discharging Managerial Responsibilities regulatory
"Transactions by Persons Discharging Managerial Responsibilities (PDMRs)"
Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.
PDMR/PCA regulatory
"Person discharging managerial responsibilities / person closely associated (PDMR/PCA)"
LEI regulatory
"Details of the issuer; LEI"
A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
24
September 2026 - “Director/PDMR
Shareholding”
|
99.1
Haleon plc: Director/PDMR
Shareholding
24 September
2026:
Haleon plc (the
“Company” or “Haleon”) (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by
Persons Discharging Managerial Responsibilities
("PDMRs").
On 24 September 2026, the Company was notified of the following
transactions as detailed below.
|
1
|
Details of the issuer, emission allowance market
participant
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Financial Officer
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the person discharging managerial responsibilities /
person closely associated (“PCA”)
|
||||
|
a)
|
PDMR/PCA
|
PDMR
|
|||
|
b)
|
Name
|
Dawn Allen
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of Instrument
Identification code
|
Share
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Currency, Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.44631
|
2,317.19703
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
22 September 2026
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
1
|
Details of the issuer, emission allowance market
participant
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Financial Officer
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the person discharging managerial responsibilities /
person closely associated (“PCA”)
|
||||
|
a)
|
PDMR/PCA
|
PDMR
|
|||
|
b)
|
Name
|
Brian McNamara
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of Instrument
Identification code
|
Share
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Currency, Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.44631
|
12,208.83196
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
22 September 2026
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of Instrument
Identification code
|
Share
US4055521003
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Currency, Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
$9.3801
|
2,139.05113
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
22 September 2026
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such as
Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date:
September 24, 2026
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|